BIODESIX INC — Director's Dealing 2020

Oct 28, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BIODESIX INC (BDSX)
CIK: 0001439725
Period of Report: 2020-10-27

Reporting Person: O'Kane Kieran (Chief Commercial Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options (Right to buy)	$0.42	2028-04-03	Common Stock (12634)		Direct
Stock Options (Right to buy)	$0.78	2028-12-31	Common Stock (12634)		Direct
Stock Options (Right to buy)	$0.78	2030-04-14	Common Stock (25269)		Direct
Stock Options (Right to buy)	$0.78	2030-04-14	Common Stock (1684)		Direct

Footnotes

F1: This option vests 40% on February 15, 2020, and the remaining 60% in 36 successive, equal monthly installments measured from February 15, 2020.

F2: This option vests in 60 successive, equal monthly installments measured from January 1, 2019.

F3: This option vests in 60 successive, equal monthly installments measured from January 1, 2020.

F4: This option vests in 60 successive, equal monthly installments measured from February 7, 2020.